Category: Hepatitis
United States Hepatitis
-
2024-2029 Hepatitis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, ... Read More
-
Hepatitis B Vaccines
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Adult Application, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.7 Billion by ... Read More
-
2024 Hepatitis Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations
... of the Hepatitis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and ... Read More
-
2024 U.S. Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations
... detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. he report provides five-year test volume and sales forecasts for HAV NAT , ... Read More
-
2024 Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The ... Read More
-
2024 US Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers
... detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
North America Point-of-Care Molecular Testing for Infectious Diseases Market Size and Forecast (2021-2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage By: Diseases (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, Strep, Others), Technology (Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Solid Phase, Others), Prescription Testing (Prescription Based Testing, OTC Testing), Sample (Blood Sample, Urine Sample, Nasal and Oropharyngeal Swabs Sample, Others), End User (Hospitals and Clinics, Home Care Settings, Ambulatory and Urgent Care Facilities, Nursing Home and Assisted Living Facilities, Research Laboratories, Diagnostics Centers), Distribution Channel (E-Com Platforms, Retail Channel and Pharmacies, Others), and Country
... Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, Strep, Others), Technology (Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Solid Phase, Others), Prescription Testing (Prescription Based Testing, OTC Testing), Sample (Blood Sample, Urine ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
Research Assistance
